161 filings
Page 5 of 9
8-K
a2pwg
18 Jun 20
Departure of Directors or Certain Officers
4:02pm
8-K
yzwnnsgfo2uajg
12 Jun 20
Submission of Matters to a Vote of Security Holders
4:37pm
8-K
sh8el0425dxv8n1hqm0e
22 May 20
Departure of Directors or Certain Officers
5:04pm
8-K
wtni8v0cffb3nn4e0x
5 May 20
Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020
4:11pm
8-K
tqhlazt1wfyk 6k9i
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
a0k0s9i ebsnm
1 Apr 20
Regulation FD Disclosure
4:39pm
8-K
zaj 1kotj
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
8-K/A
51k8caa8zl2yx6 gt
16 Mar 20
Completion of Acquisition or Disposition of Assets
5:18pm
8-K
gtidxxsu
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
exdb2b994r jfew94uu
19 Feb 20
Invitae Reports $216.8 Million in Annual Revenue Driven by More Than 482,000 Samples in 2019
4:08pm
8-K
39rtmjpwmajxqn
13 Jan 20
Results of Operations and Financial Condition
5:11pm
8-K
q3h0e9xj
13 Nov 19
Invitae to Acquire Clear Genetics
4:09pm
8-K
zn49q8hk
6 Nov 19
Invitae Reports $56.5 Million in Quarterly Revenue Driven by 129,000 Samples
4:08pm
8-K/A
c76ypgn7 57yh9zgsj5
27 Sep 19
Financial Statements and Exhibits
4:16pm
8-K
ykobe550
18 Sep 19
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:06pm
8-K
sjgcz vrs
11 Sep 19
Invitae Prices Upsized Offering of $300 Million of Convertible Senior Notes
4:07pm
8-K
tvlf1ahkzxmhjc2b8avh
4 Sep 19
Invitae Announces Proposed Offering of $200 Million of Convertible Senior Notes
4:54pm
8-K/A
7otdkh02csxnggoc
28 Aug 19
Statement of Operations
4:05pm
8-K
awst6hylkk
6 Aug 19
Invitae Reports $53.5 Million in Quarterly Revenue Driven by More Than 111,000 Samples in Quarterly Volume
4:17pm
8-K
im3tl3hb tk
17 Jul 19
Completion of Acquisition or Disposition of Assets
4:41pm